The PACER lab leads the health economics activities of this multi-year research project in collaboration with researchers from the Genome Sciences Centre and the Centre for Lymphoid Cancer. The health economic aims of the project include understanding the health-system impact and socioeconomic implications of genomics-informed relapsed care for lymphoid cancer patients.
Key articles: Costa S, Scott DW, Steidl C, Peacock SJ, Regier DA: Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia. Curr Oncol 2019, 26(2):108-113. https://www.ncbi.nlm.nih.gov/pubmed/31043812
Project funding announcement: https://www.genomecanada.ca/en/deciphering-genome-biology-relapsed-lymphoid-cancers-improve-patient-management